[HTML][HTML] Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal sarcomatosis—A systematic review and meta-analysis
LCK Wong, Z Li, Q Fan, JWS Tan, QX Tan… - European Journal of …, 2022 - Elsevier
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) play
an important role in the treatment of various peritoneal surface malignancies, but its efficacy …
an important role in the treatment of various peritoneal surface malignancies, but its efficacy …
[HTML][HTML] Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Sarcomatosis
C Yurttas, R Ladurner, AL Mihaljević, J Strohäker - Cancers, 2024 - pmc.ncbi.nlm.nih.gov
Simple Summary Surgery to remove all peritoneal metastases from soft tissue sarcoma
combined with heated intraperitoneal chemotherapy has been suggested; however, robust …
combined with heated intraperitoneal chemotherapy has been suggested; however, robust …
[HTML][HTML] Neutrophil-to-lymphocyte-ratio-based perioperative prognosis prediction model on early mortality after cytoreductive surgery with hyperthermic intraperitoneal …
HC Hung, PJ Hsu, TC Chang, HH Chou… - Asian Journal of …, 2022 - Elsevier
Background Combined cytoreductive surgery and hyperthermic intraperitoneal
chemotherapy (CRS-HIPEC) to treat peritoneal surface malignancy (PSM) has gained a …
chemotherapy (CRS-HIPEC) to treat peritoneal surface malignancy (PSM) has gained a …
[HTML][HTML] Rare histologies in peritoneal carcinomatosis: a narrative review
MU Ahmad, B Gebregziabher… - Digestive Medicine …, 2022 - dmr.amegroups.org
Methods: We performed a literature search to identify publications using PubMed from 2016
to October 13, 2021 in all languages. 37 case reports, 39 observational or retrospective …
to October 13, 2021 in all languages. 37 case reports, 39 observational or retrospective …
Outcome and Safety of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)+/-Intraoperative Radiation Therapy (IORT) in the …
A Elashwah, A Badran, MA Elshenawy… - Research in …, 2022 - journals.ekb.eg
Background: Peritoneal sarcomatosis (PS) is an aggressive disease; cytoreductive surgery
(CRS) could be curative. Aim: Can the addition of hyperthermic intraperitoneal …
(CRS) could be curative. Aim: Can the addition of hyperthermic intraperitoneal …
Patient selection for surgery for peritoneal sarcomatosis in retroperitoneal sarcoma——external validation of the Simplified Peritoneal Sarcomatosis Score
A Lv, Y Li, RZ Sun, GQ Xue, XY Tian, CY Hao - 2022 - researchsquare.com
Background Peritoneal sarcomatosis (PS) in patients with retroperitoneal sarcoma (RPS)
often indicates a poor prognosis. The Simplified Peritoneal Sarcomatosis Score (SPSS) had …
often indicates a poor prognosis. The Simplified Peritoneal Sarcomatosis Score (SPSS) had …
[PDF][PDF] Neutrophil to lymphocyte ratio based perioperative prediction of prognosis model on early mortality after cytoreductive surgery with hyperthermic intraperitoneal …
HC Hung, PJ Hsu, TC Chang, HH Chou, KG Huang… - researchgate.net
Background: Combined cytoreductive surgery and hyperthermic intraperitoneal
chemotherapy (CRSHIPEC) to treat peritoneal surface malignancy (PSM) has gained a …
chemotherapy (CRSHIPEC) to treat peritoneal surface malignancy (PSM) has gained a …